Kalaris Therapeutics Inc(KLRS)

Biotechnology · Berkeley Heights, NJ

$2.66-0.17 (-6.01%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T20:47:08.244Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:47:08.244Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -2.02
Quote price: 2.66

FMP input reference: 93c5e63ae445a2e41424364838d154d4df2cbb6a4085a726ee5a5ae15b1ce67b

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

KLRS Earnings Yield Metrics

EARNINGS YIELD

N/A

KLRS Competitors' Earnings Yield

KLRS

Kalaris Therapeutics Inc

Current

Market Cap

$58.06M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INKT

MiNK Therapeutics, Inc.

vs KLRS

Market Cap

$58.29M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BOLD

Boundless Bio, Inc.

vs KLRS

Market Cap

$57.76M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACET

Adicet Bio, Inc.

vs KLRS

Market Cap

$58.43M

Earnings Yield

N/A

TTM Avg

0.93%

3Y Avg

0.93%

5Y Avg

0.93%

PDSB

PDS Biotechnology Corporation

vs KLRS

Market Cap

$58.44M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TLPH

Talphera, Inc.

vs KLRS

Market Cap

$57.61M

Earnings Yield

N/A

TTM Avg

441.57%

3Y Avg

441.57%

5Y Avg

441.57%

CNTB

Connect Biopharma Holdings Limited

vs KLRS

Market Cap

$57.01M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XLO

Xilio Therapeutics, Inc.

vs KLRS

Market Cap

$59.18M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONCY

Oncolytics Biotech Inc.

vs KLRS

Market Cap

$60.02M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OKYO

OKYO Pharma Limited

vs KLRS

Market Cap

$56.02M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Kalaris Therapeutics Inc (KLRS)	$58.06M	N/A	N/A	N/A	N/A
MiNK Therapeutics, Inc. (INKT)vs ›	$58.29M	N/A	N/A	N/A	N/A
Boundless Bio, Inc. (BOLD)vs ›	$57.76M	N/A	N/A	N/A	N/A
Adicet Bio, Inc. (ACET)vs ›	$58.43M	N/A	0.93%	0.93%	0.93%
PDS Biotechnology Corporation (PDSB)vs ›	$58.44M	N/A	N/A	N/A	N/A
Talphera, Inc. (TLPH)vs ›	$57.61M	N/A	441.57%	441.57%	441.57%
Connect Biopharma Holdings Limited (CNTB)vs ›	$57.01M	N/A	N/A	N/A	N/A
Xilio Therapeutics, Inc. (XLO)vs ›	$59.18M	N/A	N/A	N/A	N/A
Oncolytics Biotech Inc. (ONCY)vs ›	$60.02M	N/A	N/A	N/A	N/A
OKYO Pharma Limited (OKYO)vs ›	$56.02M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield: N/A

KLRS Earnings Yield Metrics

KLRS Competitors' Earnings Yield

Earnings Yield vs P/E Ratio

Earnings Yield Formula & Definition

Related Metrics